245 related articles for article (PubMed ID: 21039540)
21. Guest Editor's Comments.
Felton LA; Porter SC
Drug Dev Ind Pharm; 2010 Feb; 36(2):127. PubMed ID: 20050729
[No Abstract] [Full Text] [Related]
22. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
23. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
24. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
Cooper VB; Pearce GE; Petts CR
J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
[TBL] [Abstract][Full Text] [Related]
25. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
26. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
Zhou Y; Chu JS; Li JX; Wu XY
Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review.
Gendrin C; Roggo Y; Collet C
J Pharm Biomed Anal; 2008 Nov; 48(3):533-53. PubMed ID: 18819769
[TBL] [Abstract][Full Text] [Related]
28. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
[TBL] [Abstract][Full Text] [Related]
29. Characterization and Quality Control of Pharmaceutical Cocrystals.
Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
[TBL] [Abstract][Full Text] [Related]
30. Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.
Box KJ; Comer J; Taylor R; Karki S; Ruiz R; Price R; Fotaki N
AAPS PharmSciTech; 2016 Apr; 17(2):245-51. PubMed ID: 26208438
[TBL] [Abstract][Full Text] [Related]
31. Tablet splitting.
Med Lett Drugs Ther; 2009 Aug; 51(1318):62-3. PubMed ID: 19661854
[TBL] [Abstract][Full Text] [Related]
32. Air-coupled non-contact mechanical property determination of drug tablets.
Akseli I; Cetinkaya C
Int J Pharm; 2008 Jul; 359(1-2):25-34. PubMed ID: 18439773
[TBL] [Abstract][Full Text] [Related]
33. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
Almarsson Ö; Peterson ML; Zaworotko M
Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
[TBL] [Abstract][Full Text] [Related]
34. Applications of Fourier transform infrared spectroscopic imaging to tablet dissolution and drug release.
Kazarian SG; Ewing AV
Expert Opin Drug Deliv; 2013 Sep; 10(9):1207-21. PubMed ID: 23682794
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical cocrystals: the coming wave of new drug substances.
Brittain HG
J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
[TBL] [Abstract][Full Text] [Related]
36. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
[TBL] [Abstract][Full Text] [Related]
37. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
38. Advanced methodologies for cocrystal synthesis.
Douroumis D; Ross SA; Nokhodchi A
Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
[TBL] [Abstract][Full Text] [Related]
39. Contribution of the physicochemical properties of active pharmaceutical ingredients to tablet properties identified by ensemble artificial neural networks and Kohonen's self-organizing maps.
Onuki Y; Kawai S; Arai H; Maeda J; Takagaki K; Takayama K
J Pharm Sci; 2012 Jul; 101(7):2372-81. PubMed ID: 22473528
[TBL] [Abstract][Full Text] [Related]
40. Solubility: it's not just for physical chemists.
Bhattachar SN; Deschenes LA; Wesley JA
Drug Discov Today; 2006 Nov; 11(21-22):1012-8. PubMed ID: 17055411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
